Perrigo reported $2.03B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Abbott USD 217.86B 15.25B Dec/2025
Bayer EUR 27.23B 2.14B Sep/2025
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Coherus Biosciences USD 278M 184M Jun/2025
Corcept Therapeutics USD 3.7B 5.05B Feb/2026
Dr.Reddys Laboratories INR 1.06T 39.78B Dec/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
Merck USD 300.37B 39.11B Feb/2026
Nestle CHF 203.11B 6.92B Jun/2025
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Phibro Animal Health USD 469M 48M Dec/2023
Prestige Brands USD 3.26B 289M Feb/2026
Reckitt Benckiser GBP 33.66B 470.56M Jun/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Supernus Pharmaceuticals USD 2.78B 226M Feb/2026
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026
Zoetis USD 57.53B 2.08B Feb/2026